In-Silico Structure Database (LMISSD)

Back
Overview
Browse
Search

LMISSD: Sum Composition Results

Abbreviation Formula Mass Main Class Sub Class
Galβ1-3Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 44:2;O2 C76H138N2O28 1526.943620 Neutral glycosphingolipids [SP05] Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
Galα1-3Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 44:1;O2 C76H140N2O28 1528.959270 Neutral glycosphingolipids [SP05] Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
Galβ1-3Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 44:1;O2 C76H140N2O28 1528.959270 Neutral glycosphingolipids [SP05] Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
Galα1-3(Fucα1-2)Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 34:1;O2 C72H130N2O32 1534.860680 Neutral glycosphingolipids [SP05] Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
GlcNAcβ1-3Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 42:2;O2 C76H137N3O28 1539.938869 Neutral glycosphingolipids [SP05] Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
GlcNAcβ1-3Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 42:1;O2 C76H139N3O28 1541.954519 Neutral glycosphingolipids [SP05] Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
Fucα1-2Galβ1-3(Fucα1-4)GlcNAcβ1-3Galβ1-4Glcβ-Cer 36:1;O2 C74H134N2O31 1546.897065 Neutral glycosphingolipids [SP05] Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
Galα1-3(Fucα1-2)Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 36:1;O2 C74H134N2O32 1562.891980 Neutral glycosphingolipids [SP05] Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
GlcNAcβ1-3Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 44:2;O2 C78H141N3O28 1567.970169 Neutral glycosphingolipids [SP05] Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
GlcNAcβ1-3Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 44:1;O2 C78H143N3O28 1569.985819 Neutral glycosphingolipids [SP05] Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
Fucα1-2Galβ1-3(Fucα1-4)GlcNAcβ1-3Galβ1-4Glcβ-Cer 38:1;O2 C76H138N2O31 1574.928365 Neutral glycosphingolipids [SP05] Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
Fucα1-4GlcNAcβ1-3Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 34:1;O2 C74H133N3O32 1575.887229 Neutral glycosphingolipids [SP05] Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
GalNAcα1-3(Fucα1-2)Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 34:1;O2 C74H133N3O32 1575.887229 Neutral glycosphingolipids [SP05] Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
GlcNAcβ1-3Galβ1-3(Fucα1-4)GlcNAcβ1-3Galβ1-4Glcβ-Cer 34:1;O2 C74H133N3O32 1575.887229 Neutral glycosphingolipids [SP05] Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
Galα1-3(Fucα1-2)Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 38:1;O2 C76H138N2O32 1590.923280 Neutral glycosphingolipids [SP05] Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
Galβ1-3GlcNAcβ1-3Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 34:1;O2 C74H133N3O33 1591.882144 Neutral glycosphingolipids [SP05] Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
Galβ1-4GlcNAcβ1-3Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 34:1;O2 C74H133N3O33 1591.882144 Neutral glycosphingolipids [SP05] Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
Fucα1-2Galβ1-3(Fucα1-4)GlcNAcβ1-3Galβ1-4Glcβ-Cer 40:1;O2 C78H142N2O31 1602.959665 Neutral glycosphingolipids [SP05] Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
Fucα1-4GlcNAcβ1-3Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 36:1;O2 C76H137N3O32 1603.918529 Neutral glycosphingolipids [SP05] Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
GalNAcα1-3(Fucα1-2)Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 36:1;O2 C76H137N3O32 1603.918529 Neutral glycosphingolipids [SP05] Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
GlcNAcβ1-3Galβ1-3(Fucα1-4)GlcNAcβ1-3Galβ1-4Glcβ-Cer 36:1;O2 C76H137N3O32 1603.918529 Neutral glycosphingolipids [SP05] Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
Galα1-3(Fucα1-2)Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 40:1;O2 C78H142N2O32 1618.954580 Neutral glycosphingolipids [SP05] Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
Galβ1-3GlcNAcβ1-3Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 36:1;O2 C76H137N3O33 1619.913444 Neutral glycosphingolipids [SP05] Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
Galβ1-4GlcNAcβ1-3Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 36:1;O2 C76H137N3O33 1619.913444 Neutral glycosphingolipids [SP05] Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
Fucα1-2Galβ1-3(Fucα1-4)GlcNAcβ1-3Galβ1-4Glcβ-Cer 42:2;O2 C80H144N2O31 1628.975315 Neutral glycosphingolipids [SP05] Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
Fucα1-2Galβ1-3(Fucα1-4)GlcNAcβ1-3Galβ1-4Glcβ-Cer 42:1;O2 C80H146N2O31 1630.990965 Neutral glycosphingolipids [SP05] Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
Fucα1-4GlcNAcβ1-3Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 38:1;O2 C78H141N3O32 1631.949829 Neutral glycosphingolipids [SP05] Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
GalNAcα1-3(Fucα1-2)Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 38:1;O2 C78H141N3O32 1631.949829 Neutral glycosphingolipids [SP05] Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
GlcNAcβ1-3Galβ1-3(Fucα1-4)GlcNAcβ1-3Galβ1-4Glcβ-Cer 38:1;O2 C78H141N3O32 1631.949829 Neutral glycosphingolipids [SP05] Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
Galα1-3(Fucα1-2)Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 42:2;O2 C80H144N2O32 1644.970230 Neutral glycosphingolipids [SP05] Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
Galα1-3(Fucα1-2)Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 42:1;O2 C80H146N2O32 1646.985880 Neutral glycosphingolipids [SP05] Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
Galβ1-3GlcNAcβ1-3Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 38:1;O2 C78H141N3O33 1647.944744 Neutral glycosphingolipids [SP05] Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
Galβ1-4GlcNAcβ1-3Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 38:1;O2 C78H141N3O33 1647.944744 Neutral glycosphingolipids [SP05] Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
Fucα1-2Galβ1-3(Fucα1-4)GlcNAcβ1-3Galβ1-4Glcβ-Cer 44:2;O2 C82H148N2O31 1657.006615 Neutral glycosphingolipids [SP05] Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
Fucα1-2Galβ1-3(Fucα1-4)GlcNAcβ1-3Galβ1-4Glcβ-Cer 44:1;O2 C82H150N2O31 1659.022265 Neutral glycosphingolipids [SP05] Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
Fucα1-4GlcNAcβ1-3Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 40:1;O2 C80H145N3O32 1659.981129 Neutral glycosphingolipids [SP05] Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
GalNAcα1-3(Fucα1-2)Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 40:1;O2 C80H145N3O32 1659.981129 Neutral glycosphingolipids [SP05] Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
GlcNAcβ1-3Galβ1-3(Fucα1-4)GlcNAcβ1-3Galβ1-4Glcβ-Cer 40:1;O2 C80H145N3O32 1659.981129 Neutral glycosphingolipids [SP05] Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
Galα1-3(Fucα1-2)Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 44:2;O2 C82H148N2O32 1673.001530 Neutral glycosphingolipids [SP05] Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
Galα1-3(Fucα1-2)Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 44:1;O2 C82H150N2O32 1675.017180 Neutral glycosphingolipids [SP05] Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
Galβ1-3GlcNAcβ1-3Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 40:1;O2 C80H145N3O33 1675.976044 Neutral glycosphingolipids [SP05] Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
Galβ1-4GlcNAcβ1-3Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 40:1;O2 C80H145N3O33 1675.976044 Neutral glycosphingolipids [SP05] Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
Galα1-3(Fucα1-2)Galβ1-3(Fucα1-4)GlcNAcβ1-3Galβ1-4Glcβ-Cer 34:1;O2 C78H140N2O36 1680.918590 Neutral glycosphingolipids [SP05] Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
Fucα1-4GlcNAcβ1-3Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 42:2;O2 C82H147N3O32 1685.996779 Neutral glycosphingolipids [SP05] Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
GalNAcα1-3(Fucα1-2)Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 42:2;O2 C82H147N3O32 1685.996779 Neutral glycosphingolipids [SP05] Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
GlcNAcβ1-3Galβ1-3(Fucα1-4)GlcNAcβ1-3Galβ1-4Glcβ-Cer 42:2;O2 C82H147N3O32 1685.996779 Neutral glycosphingolipids [SP05] Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
Fucα1-4GlcNAcβ1-3Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 42:1;O2 C82H149N3O32 1688.012429 Neutral glycosphingolipids [SP05] Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
GalNAcα1-3(Fucα1-2)Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 42:1;O2 C82H149N3O32 1688.012429 Neutral glycosphingolipids [SP05] Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
GlcNAcβ1-3Galβ1-3(Fucα1-4)GlcNAcβ1-3Galβ1-4Glcβ-Cer 42:1;O2 C82H149N3O32 1688.012429 Neutral glycosphingolipids [SP05] Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
Galβ1-3GlcNAcβ1-3Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 42:2;O2 C82H147N3O33 1701.991694 Neutral glycosphingolipids [SP05] Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]